SIMIONRGNS LTD

Executive Summary

SIMIONRGNS LTD is currently experiencing significant financial distress marked by negative equity and inadequate liquidity, heavily reliant on director loans to sustain operations. Immediate actions focusing on cash flow stabilization, capital injection, and cost control are essential to prevent insolvency and restore business viability. Without prompt intervention, the company's financial outlook remains precarious.

SIMIONRGNS LTD - Analysis Report

Company Number: 12530019

Analysis Date: 2025-07-29 20:04 UTC

Financial Health Assessment Report: SIMIONRGNS LTD (as of 31 March 2024)

---

1. Financial Health Score: D

Explanation:
SIMIONRGNS LTD shows significant financial distress as evidenced by persistent negative net assets and worsening liquidity position. The company’s working capital is deeply negative, and net liabilities have increased over recent years. This grade reflects a weak financial condition that requires urgent attention to avoid potential insolvency.

---

2. Key Vital Signs

Metric	2024 Value (£)	Interpretation
Net Assets (Shareholders’ Funds)	-2,159	Negative equity indicates the company owes more than it owns — a critical symptom of financial distress.
Net Current Assets (Working Capital)	-3,519	Negative working capital means current liabilities exceed current assets, signaling liquidity problems and possible cash flow shortages.
Cash at Bank	1,250	Low cash reserves relative to liabilities imply limited ability to meet short-term obligations immediately.
Fixed Assets (Net Book Value)	1,360	Small asset base, largely depreciated, limiting collateral value for borrowing.
Director’s Loan Account (Current Liabilities)	4,769	Significant portion of liabilities owed to the director, indicating reliance on director funding to support operations.

---

3. Diagnosis: Financial Symptoms and Underlying Business Health

• Persistent Negative Equity: The company has been in negative net asset territory since at least 2022, with shareholders’ funds deteriorating from a positive £3,668 in 2020 to a negative £2,159 in 2024. This indicates accumulated losses exceeding capital contributions, a critical warning sign akin to a patient with chronic illness that has not improved.

• Liquidity Crisis: Negative working capital across recent years (from -£3,012 in 2022 to -£3,519 in 2024) reveals a persistent liquidity shortfall. Cash reserves are minimal (£1,250 in 2024) and insufficient to cover current liabilities (£4,769), primarily director's loans. This "cash flow anemia" suggests the company may struggle to pay suppliers and creditors timely.

• Reliance on Director Funding: The entire current liabilities figure is made up of director’s loan account, implying the company depends heavily on director loans to finance its operations. This is a symptom of financial distress and an unsustainable practice over the long term without profitability improvement.

• Decreasing Asset Base: Fixed assets have declined from £3,225 in 2020 to £1,360 in 2024, reflecting depreciation and possibly no reinvestment. The company’s productive capacity may be diminishing, which could limit revenue generation potential.

• Limited Scale and Resources: With only one employee (the director) and minimal share capital (£1), the company operates on a micro scale, restricting its ability to absorb shocks or invest in growth.

• Industry Context: Operating in the "Residential care activities for the elderly and disabled" sector (SIC 87300) typically requires trust and stability. The financial weakness here could undermine operational sustainability and stakeholder confidence.

---

4. Prognosis: Future Financial Outlook

Without significant intervention, the company faces continued financial stress:

• Risk of Insolvency: Ongoing negative equity and poor liquidity raise the risk of insolvency or forced restructuring.

• Cash Flow Pressure: Limited cash and reliance on director loans may be unsustainable, risking operational disruption.

• Growth Constraints: Asset depletion and weak financial footing restrict investment in service quality or expansion.

If corrective measures are implemented promptly, there is potential for recovery, but the company must stabilize cash flow and restore profitability rapidly.

---

5. Recommendations: Prescriptions for Financial Wellness

1. Immediate Cash Flow Management:

   • Negotiate with the director for a clear repayment plan or conversion of the director’s loan into equity to reduce short-term liabilities.
   • Explore short-term financing options or overdrafts to smooth liquidity and pay critical suppliers.

2. Cost Control and Revenue Enhancement:

   • Conduct a thorough review of operating expenses to identify and eliminate inefficiencies.
   • Develop strategies to increase turnover, such as targeted marketing or service diversification, ensuring revenue growth to cover fixed costs.

3. Capital Injection:

   • Seek external investment or additional shareholder funding to strengthen equity and provide working capital buffer.

4. Financial Monitoring and Reporting:

   • Implement robust financial controls and regular cash flow forecasting to detect issues early.
   • Prepare for possible audit or financial scrutiny as the company grows or seeks investment.

5. Strategic Review:

   • Consider restructuring options, including possible merger or sale if independent recovery is unlikely.
   • Engage professional advice on insolvency prevention if cash flow does not improve.

6. Asset Management:

   • Evaluate fixed asset utilization and potential sale of non-essential assets to improve liquidity.

---

Medical Analogy Summary:
SIMIONRGNS LTD’s financial "vital signs" reveal a company in "critical condition" with symptoms of liquidity anemia and equity deficiency. The financial "heart"—cash flow—is weak, reliant on director loans as a life support system. Without immediate intervention, the prognosis is poor, but targeted treatment through cash flow management and capital restructuring can restore financial health.

---